Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP

Last updated on 2021-10-16 History
Report ID 147161
Drug Identification Number 02485540
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Common or Proper name Hydromorphone Hydrochloride Injection USP
Company Name STERINOVA INC.
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 30 x 100 mL
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-10-15
Actual start date 2021-10-15
Estimated end date 2021-11-05
Actual end date
Shortage status Actual shortage
Updated date 2021-10-16
Company comments Alternative format of Hydromorphone Hydrochloride Injection USP, 20 mg/ 50 mL available.
Health Canada comments
Contact Address 3005 AVENUE JOSE-MARIA ROSELL
SAINT-HYACINTHE, QUEBEC
CANADA J2S 0J9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-10-16 English Compare
v3 2021-10-14 French Compare
v2 2021-10-14 French Compare
v1 2021-10-14 English Compare